Archive | May, 2020

Congratulations to AYRO, Inc. (Nasdaq: AYRO) on completion of merger and listing on Nasdaq.

DropCar and AYRO Stockholders Approve Merger AYRO, Inc. Common Shares to Trade on NASDAQ under the Ticker Symbol “AYRO” Commencing May 29, 2020 Virtual “Town Hall” for Investors to Discuss AYRO Vehicle Roadmap and Strategic Partnership with Club Car Slated for June 2, 2020 May 28, 2020 02:49 PM Eastern Daylight Time NEW YORK & […]

Leave a comment Continue Reading →

Congratulations to Qualigen Therapeutics, Inc. (QLGN) on the merger and new listing on Nasdaq Capital Market.

Qualigen Therapeutics Announces Merger Closing Common stock begins trading today on NASDAQ under the ticker QLGN Company raises $4 million in a private placement News provided by Qualigen, Inc. May 26, 2020, 07:00 ET Share this article CARLSBAD, Calif., May 26, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) (formerly known as […]

Leave a comment Continue Reading →

Congratulations to Windtree Therapeutics, Inc. on the $20 million offering and relisting on The Nasdaq Capital Market.

Windtree Therapeutics Announces Pricing of $20.0 Million Public Offering and Uplisting to the Nasdaq Capital Market WARRINGTON, Pa., May 20, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced the pricing of […]

Leave a comment Continue Reading →

Congratulations to Timber Pharmaceuticals, Inc. (TMBR) on the merger and new listing on NYSE American.

Leave a comment Continue Reading →

Congratulations to Delcath Systems, Inc. on the re-IPO and listing on The Nasdaq Capital Market.

Delcath Systems announced the pricing of its public offering raising $22 million. Roth Capital acted as sole book-runner. NEW YORK, May 01, 2020 (GLOBE NEWSWIRE) — Delcath Systems, Inc. (OTCQB:DCTH  NASDAQ:DCTH), an interventional oncology company focused on the treatment of rare primary and metastatic cancers of the liver, today announced the pricing of a $22 […]

Leave a comment Continue Reading →